» Articles » PMID: 27273820

Cognitive Impairment is Independently Associated with Definitive and Possible Sarcopenia in Hospitalized Older Adults: The Prevalence and Impact of Comorbidities

Overview
Specialty Geriatrics
Date 2016 Jun 9
PMID 27273820
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: Older adults often present with several comorbidities, including sarcopenia. However, the prevalence of sarcopenia and its associations with other comorbidities in hospitalized older adults are unknown. The present study aimed to determine the prevalence of sarcopenia, and its associations with other comorbidities in hospitalized older adults.

Methods: The present cross-sectional study included 619 patients admitted to a geriatric hospital. The prevalence of comorbidities in the presence and absence of sarcopenia, nutritional status (according to body mass index and the Mini-Nutritional Assessment-Short Form), and activities of daily living (according to the Barthel Index) were assessed. Sarcopenia was defined as skeletal muscle loss evaluated by both bioelectrical impedance and handgrip strength analyses.

Results: Of the 619 participants (mean age 83.0 ± 8.2 years), 417 (67.4%) and 87 (14.1%) had definitive and possible sarcopenia, respectively. The prevalence rates of cognitive impairment and stroke were significantly higher in patients with definitive sarcopenia and those with possible sarcopenia than in those without sarcopenia (cognitive impairment 54.4%, 70.1% and 20.9%, respectively, P < 0.001; stroke 31.2%, 48.3% and 19.1%, respectively, P < 0.001). Multivariate logistic regression analysis showed that cognitive impairment was independently associated with sarcopenia after adjusting for age, sex, the Mini-Nutritional Assessment-Short Form score, Barthel Index and primary disease (adjusted odds ratio 1.98, 95% confidence interval 1.06-3.71; P = 0.032).

Conclusions: Sarcopenia might be highly prevalent among hospitalized older adults. Furthermore, cognitive impairment might be an independent explanatory variable of sarcopenia. Therefore, further studies on sarcopenia in patients with cognitive impairment are warranted. Geriatr Gerontol Int 2017; 17: 1048-1056.

Citing Articles

Association between dietary variety status and sarcopenia as defined by the Asian Working Group for Sarcopenia 2019 consensus in older outpatients at a hospital specializing in geriatric medicine: A cross‑sectional study with baseline data of....

Asaoka D, Sugano K, Matsuno K, Shibata N, Sugiyama H, Endo N Biomed Rep. 2024; 21(2):123.

PMID: 38978536 PMC: 11229399. DOI: 10.3892/br.2024.1811.


Effects of Cognitive-Motor and Motor-Motor Dual Tasks on Gait Performance in Older Adults with Sarcopenia.

Wang C, Jin B, Lu A Healthcare (Basel). 2024; 12(12).

PMID: 38921320 PMC: 11203043. DOI: 10.3390/healthcare12121206.


Validation of SARC-F-Proxy for the Screening of Sarcopenia in Older Patients with Cognitive Impairment.

Lamers S, Kasim Z, Rodriguez-Garcia W, Kalmet P, Perkisas S, De Cock A J Frailty Sarcopenia Falls. 2023; 8(4):204-210.

PMID: 38046439 PMC: 10690132. DOI: 10.22540/JFSF-08-204.


Exploring the Intricate Nexus of Sarcopenia and Cognitive Impairment.

Xing Y, Li X, Ma L Aging Dis. 2023; 15(6):2334-2344.

PMID: 37962457 PMC: 11567264. DOI: 10.14336/AD.2023.1013.


Associations of screen-based sedentary activities with all cause dementia, Alzheimer's disease, vascular dementia: a longitudinal study based on 462,524 participants from the UK Biobank.

Yuan S, Li W, Ling Y, Huang X, Feng A, Tan S BMC Public Health. 2023; 23(1):2141.

PMID: 37919716 PMC: 10621115. DOI: 10.1186/s12889-023-17050-3.